Bashan Dror's Form 4 filing
Protalix BioTherapeutics, Inc. (PLX) · filed Oct 20, 2023
- Accession no.
- 0001415889-23-014454
- Filed
- Oct 20, 2023
- Trade date
- Oct 19, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $90.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bashan DrorCIK 0001781450 | Director, Officer (PRESIDENT AND CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 19, 2023 | Common Stock | PPurchaseAcquired | +48,387 | $1.40 | +$67,741.8 | 116,387 | Direct | |
| Oct 19, 2023 | Common Stock | PPurchaseAcquired | +16,129 | $1.41 | +$22,741.89 | 132,516 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.